Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.53 - $0.93 $3,538 - $6,209
6,677 Added 4.42%
157,859 $91,000
Q4 2023

Feb 12, 2024

BUY
$0.63 - $1.14 $23,439 - $42,414
37,206 Added 32.64%
151,182 $125,000
Q3 2023

Nov 13, 2023

BUY
$1.12 - $1.88 $8,085 - $13,571
7,219 Added 6.76%
113,976 $128,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $2.04 $26,860 - $41,828
-20,504 Reduced 16.11%
106,757 $170,000
Q1 2023

May 12, 2023

SELL
$1.45 - $2.95 $149,602 - $304,363
-103,174 Reduced 44.77%
127,261 $193,000
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $237,202 - $381,637
117,427 Added 103.91%
230,435 $553,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $33,839 - $54,212
17,265 Added 18.03%
113,008 $231,000
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $8,793 - $17,856
6,764 Added 7.6%
95,743 $185,000
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $1,731 - $2,557
737 Added 0.84%
88,979 $219,000
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $867,578 - $1.71 Million
-297,116 Reduced 77.1%
88,242 $284,000
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $1.58 Million - $2.1 Million
317,486 Added 467.77%
385,358 $2.02 Million
Q2 2021

Aug 17, 2021

BUY
$2.56 - $5.49 $73,528 - $157,683
28,722 Added 73.36%
67,872 $373,000
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $12,998 - $25,368
4,832 Added 14.08%
39,150 $107,000
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $44,208 - $62,617
-13,946 Reduced 28.9%
34,318 $110,000
Q3 2020

Nov 16, 2020

SELL
$2.98 - $5.2 $8,531 - $14,887
-2,863 Reduced 5.6%
48,264 $194,000
Q2 2020

Aug 14, 2020

SELL
$2.29 - $4.24 $175,773 - $325,449
-76,757 Reduced 60.02%
51,127 $202,000
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $60,896 - $139,237
31,717 Added 32.98%
127,884 $313,000
Q4 2019

Feb 14, 2020

SELL
$2.41 - $4.4 $132,345 - $241,626
-54,915 Reduced 36.35%
96,167 $391,000
Q3 2019

Nov 14, 2019

BUY
$2.17 - $3.14 $327,847 - $474,397
151,082 New
151,082 $390,000
Q2 2019

Aug 14, 2019

SELL
$2.53 - $3.04 $37,074 - $44,548
-14,654 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$2.51 - $3.73 $2,482 - $3,688
-989 Reduced 6.32%
14,654 $44,000
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $24,872 - $41,610
15,643 New
15,643 $37,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.